CI: Cigna Corp Stock

SIC 6324 – Hospital and Medical Service Plans

Valuation
Market Cap ($M) 92,189.48
Enterprise Value ($M) 116,679.48
Book Value ($M) 45,133.00
Book Value / Share 147.62
Price / Book 2.04
NCAV ($M) -68,919.00
NCAV / Share -225.42
Price / NCAV -1.34

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.14

Liquidity (mrq)
Quick Ratio 0.64
Current Ratio 0.73

Balance Sheet (mrq) ($M)
Current Assets 30,157.00
Assets 144,209.00
Liabilities 99,076.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Effect Of Dilution n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Dodge & Cox 5.30 62.88
02-14 13G/A Price T Rowe Associates Inc /md/ 5.40 -39.89
02-09 13G/A Vanguard Group Inc 7.88 -6.06
02-09 13G/A Fmr Llc 4.74 -19.51
2022-02-03 13G/A BlackRock Inc. 8.90 5.79

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT
2022-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S
2022-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO
2022-02-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-02-02 280,615 1,858,773 15.10
2023-02-01 161,978 985,018 16.44
2023-01-31 159,941 993,761 16.09
2023-01-30 206,030 1,282,517 16.06

(click for more detail)

Similar Companies
AFL – AFLAC Incorporated ANTM – Anthem Inc
BHG – Bright Health Group, Inc. CNC – Centene Corp
CNO – CNO Financial Group Inc


Financial data and stock pages provided by
Fintel.io